Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Verismo Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Verismo Therapeutics

Verismo Therapeutics

Verismo Therapeutics: Pioneering enhanced T-cell immunotherapy for hard-to-treat cancers.

HQ
Philadelphia, PA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Verismo Therapeutics, founded with a mission to revolutionize cancer treatment, focuses on developing advanced chimeric antigen receptors (CARs) to enhance T-cell-based immunotherapy, particularly for solid tumors and non-hematologic malignancies. Their flagship technology, the KIR-CAR platform, aims to reduce T-cell exhaustion and improve efficacy in killing solid tumor cells, addressing a significant gap in current cancer therapies.

Notable figures affiliated with Verismo Therapeutics include leading scientists and industry experts in cellular immunotherapy. The company has garnered attention from prominent investors in the biotech sector. Key achievements include successful in vivo studies demonstrating the effectiveness of their KIR-CAR construct. Verismo's innovative approach has the potential to significantly impact cancer treatment paradigms, offering new hope for patients with hard-to-treat cancers.

Verismo Therapeutics - Similar Companies

Verseau Therapeutics logo

Verseau Therapeutics

verseautx.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

CERo Therapeutics logo

CERo Therapeutics

cero.bio

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

AffyImmune Therapeutics logo

AffyImmune Therapeutics

affyimmune.com

Chimera Bioengineering logo

Chimera Bioengineering

chimera.bio

Affini-T Therapeutics logo

Affini-T Therapeutics

affinittx.com

Inceptor Bio logo

Inceptor Bio

inceptor.bio

Veru logo

Veru

verupharma.com

Virsti Therapeutics logo

Virsti Therapeutics

Carisma Therapeutics logo

Carisma Therapeutics

carismatx.com

Tactiva Therapeutics logo

Tactiva Therapeutics

Telo Therapeutics logo

Telo Therapeutics

Verastem logo

Verastem

Allogene Therapeutics logo

Allogene Therapeutics

allogene.com

Verismo Therapeutics - Quick Facts

Who are Verismo Therapeutics' competitors?

Companies similar to Verismo Therapeutics include Verseau Therapeutics, Immpact Bio, CERo Therapeutics and A2 Biotherapeutics.

When was Verismo Therapeutics founded?

Verismo Therapeutics was founded in 2020.

Where is Verismo Therapeutics' headquarters located?

Verismo Therapeutics' headquarters is located in Philadelphia, PA, US.

When was Verismo Therapeutics' last funding round?

Verismo Therapeutics' most recent funding round was for $17M (USD) in July 2023.

How much has Verismo Therapeutics raised to-date?

As of Jul 18, 2023, Verismo Therapeutics has raised a total of $40M (USD).

How many employees does Verismo Therapeutics have?

Verismo Therapeutics has 14 employees as of Feb 5, 2024.

Verismo Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • CAR T-Cell Therapy
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified